Logo image of ALCHI.PA

ALCHIMIE SAS (ALCHI.PA) Stock Fundamental Analysis

EPA:ALCHI - Euronext Paris - Matif - FR0014000JX7 - Common Stock - Currency: EUR

0.252  +0.01 (+5%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ALCHI. ALCHI was compared to 42 industry peers in the Entertainment industry. Both the profitability and financial health of ALCHI have multiple concerns. ALCHI has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALCHI had negative earnings in the past year.
ALCHI had a negative operating cash flow in the past year.
In the past 5 years ALCHI always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: ALCHI reported negative operating cash flow in multiple years.
ALCHI.PA Yearly Net Income VS EBIT VS OCF VS FCFALCHI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2M -2M -4M -6M -8M

1.2 Ratios

ALCHI's Return On Assets of -16.93% is on the low side compared to the rest of the industry. ALCHI is outperformed by 76.19% of its industry peers.
Industry RankSector Rank
ROA -16.93%
ROE N/A
ROIC N/A
ROA(3y)-18.81%
ROA(5y)-17.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALCHI.PA Yearly ROA, ROE, ROICALCHI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 200 400 600 800 1K

1.3 Margins

ALCHI has a Operating Margin (0.89%) which is in line with its industry peers.
With a decent Gross Margin value of 60.80%, ALCHI is doing good in the industry, outperforming 64.29% of the companies in the same industry.
ALCHI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.89%
PM (TTM) N/A
GM 60.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.1%
GM growth 5Y-0.12%
ALCHI.PA Yearly Profit, Operating, Gross MarginsALCHI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

ALCHI does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALCHI has more shares outstanding than it did 1 year ago.
ALCHI has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ALCHI is higher compared to a year ago.
ALCHI.PA Yearly Shares OutstandingALCHI.PA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
ALCHI.PA Yearly Total Debt VS Total AssetsALCHI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -2.10, we must say that ALCHI is in the distress zone and has some risk of bankruptcy.
ALCHI has a worse Altman-Z score (-2.10) than 88.10% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.1
ROIC/WACCN/A
WACC2.31%
ALCHI.PA Yearly LT Debt VS Equity VS FCFALCHI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 0.56 indicates that ALCHI may have some problems paying its short term obligations.
ALCHI has a Current ratio of 0.56. This is in the lower half of the industry: ALCHI underperforms 64.29% of its industry peers.
A Quick Ratio of 0.56 indicates that ALCHI may have some problems paying its short term obligations.
The Quick ratio of ALCHI (0.56) is worse than 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.56
ALCHI.PA Yearly Current Assets VS Current LiabilitesALCHI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ALCHI have decreased strongly by -164.19% in the last year.
ALCHI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -48.67%.
Measured over the past years, ALCHI shows a very negative growth in Revenue. The Revenue has been decreasing by -21.80% on average per year.
EPS 1Y (TTM)-164.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.04%
Revenue 1Y (TTM)-48.67%
Revenue growth 3Y-26.86%
Revenue growth 5Y-21.8%
Sales Q2Q%-31.78%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y88.89%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.54%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALCHI.PA Yearly Revenue VS EstimatesALCHI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ALCHI.PA Yearly EPS VS EstimatesALCHI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 0 -0.5 -1 -1.5 -2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ALCHI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 1.44, the valuation of ALCHI can be described as very cheap.
Based on the Price/Forward Earnings ratio, ALCHI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 20.42. ALCHI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 1.44
ALCHI.PA Price Earnings VS Forward Price EarningsALCHI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALCHI is valued cheaply inside the industry as 95.24% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.66
ALCHI.PA Per share dataALCHI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

ALCHI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALCHI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALCHIMIE SAS

EPA:ALCHI (5/8/2025, 7:00:00 PM)

0.252

+0.01 (+5%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)01-30 2025-01-30/amc
Earnings (Next)10-23 2025-10-23
Inst Owners0.74%
Inst Owner ChangeN/A
Ins Owners16.24%
Ins Owner ChangeN/A
Market Cap1.13M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.44
P/S 0.1
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 1.66
EPS(TTM)-0.42
EYN/A
EPS(NY)0.18
Fwd EY69.48%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS2.52
BVpS-0.85
TBVpS-1.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.93%
ROE N/A
ROCE -2.93%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 0.89%
PM (TTM) N/A
GM 60.8%
FCFM N/A
ROA(3y)-18.81%
ROA(5y)-17.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.1%
GM growth 5Y-0.12%
F-Score4
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0.07
Cap/Depr 45.64%
Cap/Sales 5.41%
Interest Coverage 20.2
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.56
Altman-Z -2.1
F-Score4
WACC2.31%
ROIC/WACCN/A
Cap/Depr(3y)67.28%
Cap/Depr(5y)114.4%
Cap/Sales(3y)5.8%
Cap/Sales(5y)6.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-164.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.04%
EPS Next Y88.89%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-48.67%
Revenue growth 3Y-26.86%
Revenue growth 5Y-21.8%
Sales Q2Q%-31.78%
Revenue Next Year1.54%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-96.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-821.18%
FCF growth 3YN/A
FCF growth 5Y-16.07%
OCF growth 1Y-100%
OCF growth 3YN/A
OCF growth 5Y-14.32%